• Follow us
  • EN
    Flag Indonesia ID
    Flag English EN
Logo header Biofarma Group & Bio Farma Member of Biofarma Group -01 (1)
  • About Us
    • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Management Team
      • Commisioners
      • Directors
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • TJSL
    • LHKPN
      • Lapor
  • Career
    • Recruitment
    • FAQ
  • PPID
  • Contact Us
search

Good Corporate Governance

In order to build good corporate governance, the Company shall have a commitment, consistent, and persistent from all relevant parties, i.e : all management levels, Employees, Board of Commissioners, Government and other Stakeholders.

  • Good Corporate Governance
  • Quality Assurance Control
  • Responsibilty to Customer
  • Corporate Governance Implementation Process
  • Gratification Control Process
  • Process of Whistle Blowing System
  • Guidelines for The Board of Commisioner and Director
  • Biofarma Code of Conduct
  • Guidelines for Handling Conflict of Interest
  • Charter
    • Internal Audit Charter
    • AUDIT COMMITTEE CHARTER
    • Risk Committee Charter
  • Risk Management
  • Directors Guidelines
  • Audit Committee
  • Development Risk and GCG Committee
  • Superior Performance Assessment Criteria
Select Menu

COMMITMENT & POLICY ON RISK MANAGEMENT IMPLEMENTATION

As a form of PT Bio Farma (Persero)'s commitment to implementing effective Good Corporate Governance in accordance with the Regulation of the Minister of SOEs No.1 of 2011 which requires SOEs to implement risk management, the Company has established the Compliance & Risk Management Division (Risk Management Management Unit) which is responsible to SEPV Legal & Compliance.

 

 

OBJECTIVES OF RISK MANAGEMENT IMPLEMENTATION POLICY

  1. The realization of a joint commitment to implement Risk Management;
  2. Availability of adequate regulations and guidelines for the implementation of Risk Management;
  3. Availability of Risk Management documents, follow-up plans, monitoring and evaluation of follow-up risk management;
  4. Implementation of Risk Management that supports an effective internal control system;
  5. The realization of continual improvement in the implementation of Risk Management;
  6. Improving the Company's readiness in the face of increasing uncertainty that has the potential to threaten resources and even the continuity of the Company;
  7. Keeping the Company in the corridor of prudent business management (prudent operational) in every activity it carries out.

 

SCOPE OF RISK MANAGEMENT IMPLEMENTATION

Each Risk Owner is obliged to manage the Risk of its work unit.

Implementation of Risk Management as:

 

  1. Kategori Risiko :

  1. STANDAR ACUAN PENERAPAN MANAJEMEN RISIKO (ISO 31000 : 2018)

 

PELAPORAN PENERAPAN MANAJEMEN RISIKO

  1. Laporan Manajemen Risiko

 

 

  1. Laporan Monitoring & Evaluasi Kegiatan Penanganan Risiko

 

RISIKO PERUSAHAAN TAHUN 2020

  • Good Corporate Governance
  • Quality Assurance Control
  • Responsibilty to Customer
  • Corporate Governance Implementation Process
  • Gratification Control Process
  • Process of Whistle Blowing System
  • Guidelines for The Board of Commisioner and Director
  • Biofarma Code of Conduct
  • Guidelines for Handling Conflict of Interest
  • Charter
    • Internal Audit Charter
    • AUDIT COMMITTEE CHARTER
    • Risk Committee Charter
  • Risk Management
  • Directors Guidelines
  • Audit Committee
  • Development Risk and GCG Committee
  • Superior Performance Assessment Criteria

Logo biofarma

Call Center 1500810
Head Office
Jl. Pasteur No. 28, Bandung 40161,
Jawa Barat Indonesia
+62 22-2033755
+62 22 - 2041306
mail@biofarma.co.id

Breeding Facility Bio Farma
Jl. Kolonel Masturi Kav 10. Desa Kertawangi kec. Cisarua
Jawa Barat
Bio Farma Representative Office
Gd. Pakarti centre Lantai 7
Jln. Tanah Abang 3 no.23-27
Jakarta Pusat

Digital Healthcare Office Jakarta Lt. 26
Equity Tower Sudirman Central Business District (SCBD) Lot 9
Jl. Jend. Sudirman Kav. 52-53
Jakarta Selatan 12190, Indonesia
Information
  • Good Corporate Governance
  • Our Procurement
  • FAQ
  • Vaccine Production
  • Your Career
 
  • Contact Us
  • E-PPID
  • Announcement
  • I Want to
  • Media Release
Our Partner

Quick Links
  • Portal BUMN-Bio
  • Kemenkes RI
Copyright © 2023. All Rights Reserved by Bio Farma

Change Language

EN
  • About Us
    • Company Profile
      • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Management Team
      • Commisioners
      • Directors
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • TJSL
    • LHKPN
      • Lapor
  • Career
    • Career
    • Recruitment
    • FAQ
  • PPID
  • Contact Us
  • Follow us
Change Language
  • Flag Indonesia ID
  • Flag English EN